Tuesday, November 15, 2016
10:30 AM - 11:30 AM EST / 7:30 AM - 8:30 AM PST
via CHANGE
HIV, PrEP, and Adolescent Girls and Young Women: Understanding the evidence
At the 2016 International AIDS Conference, three studies led by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) provided important new evidence on the biological and structural factors that contribute to the high HIV burden among young women and girls. Join CHANGE for an interactive webinar with CAPRISA director, Professor Salim Abdool Karim, who will discuss this groundbreaking new research and implications for the future of HIV prevention for girls and young women.
Speakers:
Salim Abdool Karim, Director, Centre for the AIDS Programme of Research in South Africa (CAPRISA)
Professor Salim S Abdool Karim, MBChB, PhD, DSc (honoris causa) is a South African clinical infectious diseases epidemiologist who is widely recognized for his groundbreaking scientific contributions in HIV prevention and treatment. He is Director of CAPRISA; CAPRISA Professor of Global Health at the Mailman School of Public Health at Columbia University; Adjunct Professor of Medicine at Weill Medical College of Cornell University; and Associate Member of The Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard University.
His contributions to microbicides for HIV prevention spans two decades and culminated in the CAPRISA 004 tenofovir gel trial which provided proof-of-concept that antiretroviral drugs can prevent sexually transmitted HIV infection and herpes simplex virus type 2 in women. He is co-inventor on patents which have been used in several HIV vaccine candidates and his clinical research on TB-HIV treatment has shaped international guidelines on the clinical management of co-infected patients.
Bergen Cooper, Director of Policy Research, CHANGE (moderator)
To register for this webinar, click here.
